Atrial Myxoma-Related to Chronic Immunosuppression: A Case Report
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
Although rare, atrial myxoma is the most common primary tumour of the heart. Its relation to immunosuppression in solid organ transplant is presently debateable. We report the case of a 71-year-old male patient who underwent renal transplant 17 years prior. Since that time he continued high dose immunosuppression without physician consultation and presented to us with atrial myxoma and its complications raising the question of any association between immunosuppression and the development of atrial myxoma.
References
1.
Dadkhah R, Decoodt P
. Cardiac myxoma: related to immunosuppression? A case report. Acta Cardiol. 2009; 64(4):571-3.
DOI: 10.2143/AC.64.4.2041629.
View
2.
Gutierrez-Dalmau A, Campistol J
. Immunosuppressive therapy and malignancy in organ transplant recipients: a systematic review. Drugs. 2007; 67(8):1167-98.
DOI: 10.2165/00003495-200767080-00006.
View
3.
Mihalov M, Gattuso P, Abraham K, Holmes E, Reddy V
. Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center. Clin Transplant. 1996; 10(3):248-55.
View
4.
Sakamoto H, Sakamaki T, Kanda T, Hirao Y, Ohyama Y, Ogishi K
. Immunosuppressive drugs inhibit the production of interleukin-6 and interleukin-8 in cultured cardiac myxoma cells. Res Commun Mol Pathol Pharmacol. 1997; 97(1):60-6.
View
5.
Dufkova B, Malek I, Vymetalova Y, Hoskova L, Skalsky I, Pirk J
. Myxoma of donor origin in a transplanted heart. J Heart Lung Transplant. 2007; 26(8):865-7.
DOI: 10.1016/j.healun.2007.05.021.
View